News – Page 396 – Endpoints News

Parthenon Therapeutics CEO exits weeks after co-founder leaves

3 years ago

Tonix snaps up assets from Healion Bio; Mesoblast gives its BLA another shot

3 years ago

Incoming Roche CEO builds out his top team, tapping Genentech vet to lead pharma division

3 years ago

#JPM23: Is 2023 going to be a better year for biotech dealmaking?

3 years ago

Roche ditches final PhIII for cancer hopeful, reports setback for key drug in $1.4B buyout

3 years ago

FDA approves GSK's anemia drug with safety warning — after batting back similar drugs

3 years ago

After a busy year of buildouts, Thermo Fisher sets plans for growth in 2023

3 years ago

GSK doubles down on vaccines, HIV meds as CEO Emma Walmsley touts 'landmark' 2022

3 years ago

City of Hope rebrands acquired Cancer Treatment Centers of America network under its own name

3 years ago

FDA axes requirement for positive Covid test before Paxlovid use

3 years ago

Novo Nordisk notches big GLP-1 sales amid rebounding supplies, but cautions on future 'periodic constraints'

3 years ago

Going blockbuster hunting, Vas Narasimhan outlines vision for ‘pure-play’ Novartis

3 years ago

Pfizer brings Ibrance to new subset of breast cancer patients, regardless of menopausal status

3 years ago

Prothena unveils healthy volunteer safety data for Alzheimer's drug in Bristol Myers collab

3 years ago

KKR healthcare vet Jim Momtazee’s investment firm closes $3.9B inaugural fund

3 years ago

Simba Gill staying on at Evelo to weather layoffs and a PhII fail

3 years ago

GreenLight's mRNA vaccine nabs trial OK; Ratio reels in radiotherapy funds

3 years ago

'Moonshot' at liver cell therapy biotech Ambys Medicines comes to an end

3 years ago

GSK drops celiac drug, anti-bacterial vaccine in latest pipeline sweep

3 years ago

2022 was about execution. Now will Amgen's growth strategy prove its worth?

3 years ago

Updated: Novartis rejigs late-stage plans for Cosentyx, next-gen CAR-T, TIGIT antibody and more

3 years ago

Cell therapy biotech shifts focus to UK, makes deep cuts to US headcount

3 years ago

New competitors push Sanofi to offer voluntary retirement packages at two Indian sites

3 years ago

Pfizer's Albert Bourla spells out 'transition year' for Covid products, with sales expected to reach a low point

3 years ago

First page Previous page 393 394 395396397 398 399 Next page Last page